FGF21 and obesity due to melanocortin 4 receptor deficiency: The metabolic function of FGF21 was first described in 2005 in a seminal publication that outlined its capacity to increase glucose uptake in adipocytes, and its ability to protect against obesity, hyperglycaemia, and hypertriglyceridemia in mice [42].